Puma Biotechnology (PBYI) Return on Capital Employed Growth (5y) (2017 - 2026)
Puma Biotechnology (PBYI) Return on Capital Employed Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,015.37 Bn | 1,015.37 Bn | - |
| 4 | BeOne Medicines | 471.39 Bn | 466.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.52 Bn | 115.28 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.33 Bn | 61.58 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Puma Biotechnology | 414.64 Mn | 376.36 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,677.00 |
| Dec 31, 2025 | 5,098.00 |
| Sep 30, 2025 | 4,820.00 |
| Jun 30, 2025 | 5,969.00 |
| Mar 31, 2025 | 7,673.00 |
| Dec 31, 2024 | 5,298.00 |
| Sep 30, 2024 | 6,476.00 |
| Jun 30, 2024 | 4,155.00 |
| Mar 31, 2024 | 5,261.00 |
| Dec 31, 2023 | 8,097.00 |
| Sep 30, 2023 | 10,223.00 |
| Jun 30, 2023 | 16,805.00 |
| Mar 31, 2023 | 23,952.00 |
| Dec 31, 2022 | 27,132.00 |
| Sep 30, 2022 | 39,179.00 |
| Jun 30, 2022 | 20,336.00 |
| Mar 31, 2022 | 13,181.00 |
| Dec 31, 2021 | 17,855.00 |
| Sep 30, 2021 | 21,830.00 |
| Jun 30, 2021 | 15,847.00 |